- Home
- BLCO vs BOOT Comparison
BLCO vs BOOT Comparison
Compare BLCO & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- BOOT
- Stock Information
- Founded
- BLCO 1853
- BOOT 1978
- Country
- BLCO Canada
- BOOT United States
- Employees
- BLCO N/A
- BOOT N/A
- Industry
- BLCO Ophthalmic Goods
- BOOT Clothing/Shoe/Accessory Stores
- Sector
- BLCO Health Care
- BOOT Consumer Discretionary
- Exchange
- BLCO Nasdaq
- BOOT Nasdaq
- Market Cap
- BLCO 4.0B
- BOOT 3.3B
- IPO Year
- BLCO 2022
- BOOT 2014
- Fundamental
- Price
- BLCO $11.45
- BOOT $160.29
- Analyst Decision
- BLCO Hold
- BOOT Strong Buy
- Analyst Count
- BLCO 12
- BOOT 13
- Target Price
- BLCO $15.59
- BOOT $173.77
- AVG Volume (30 Days)
- BLCO 850.1K
- BOOT 1.0M
- Earning Date
- BLCO 04-30-2025
- BOOT 05-14-2025
- Dividend Yield
- BLCO N/A
- BOOT N/A
- EPS Growth
- BLCO N/A
- BOOT 22.50
- EPS
- BLCO N/A
- BOOT 5.88
- Revenue
- BLCO $4,829,000,000.00
- BOOT $1,911,104,000.00
- Revenue This Year
- BLCO $6.97
- BOOT $15.85
- Revenue Next Year
- BLCO $5.44
- BOOT $12.42
- P/E Ratio
- BLCO N/A
- BOOT $27.26
- Revenue Growth
- BLCO 11.94
- BOOT 14.64
- 52 Week Low
- BLCO $10.45
- BOOT $86.17
- 52 Week High
- BLCO $21.69
- BOOT $176.64
- Technical
- Relative Strength Index (RSI)
- BLCO 44.25
- BOOT 71.69
- Support Level
- BLCO $10.99
- BOOT $153.01
- Resistance Level
- BLCO $12.05
- BOOT $164.04
- Average True Range (ATR)
- BLCO 0.41
- BOOT 5.73
- MACD
- BLCO 0.08
- BOOT 0.73
- Stochastic Oscillator
- BLCO 35.38
- BOOT 84.16
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.